PMS-Ranitidine 150mg(2021-02-04)
- Starting date:
- February 4, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-74955
Last updated:
2021-02-05
Summary
-
Product:
PMS-Ranitidine 150mg
Reason
Presence of N-nitrosodimethylamine (NDMA) close to the acceptable concentration limit in affected lots.
Depth of distribution
Retailers
Affected products
PMS-Ranitidine 150mg
DIN, NPN, DIN-HIM
DIN 02242453
Dosage form
Tablet
Strength
Ranitidine hydrochloride 150mg
Lot or serial number
623633, 624871, 626714, 626718
Companies
- Recalling Firm
-
Pharmascience Inc.
6111 Royalmount Avenue, Office 100
Montréal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
6111 Royalmount Avenue, Office 100
Montréal
H4P 2T4
Quebec
CANADA